click below
click below
Normal Size Small Size show me how
Stack #200709
Medications/ Diabetes
| Question | Answer |
|---|---|
| oral hypoglycemics | oral meds to lower BS |
| Action of Sulfonylureas | Drugs that stimulate beta cells to release more insulin |
| Action of Meglitinide | Drugs that stimulate beta cells to release more insulin |
| Action of Alpha-Glucose Inhibitor | Slows or blocks the breakdown if starches and certain sugars; action slows the rise in BS after meals |
| Action of Biguanide | Senitizes the bodies to the insulin already present |
| Action of DPP-4 Inhibitors | These drugs block an enzyme that normally deactivated a protein (GLP-1) that keeps insulin circulating in the blood |
| Action of Incretin Mimetics (subcutaneous) | These mimic the action of specific hormones which help the body make more insulin |
| Sulfonylureas | glipizide (Glucotrol, Glucotrol XL); glyburide (Micronase, DiaBeta, Glynase)glimepiride (Amaryl) |
| Meglitinide | repaglinide (Prandin);nataglinide (Starlix) |
| Biguanide | metformin (Glucophage, Glucophage XR, Riomet, Fortamet) |
| Alpha-Glucose Inhibitor | Acarbose (Precose); Miglitol (Glyset) |
| DPP-4 Inhibitors | sitagliptin (Januvia); vildagliptin (Galvus) |
| Incretin Mimetics | exenatide (Byetta) |
| Action of Thiazolidinedions | increase glucose uptake in the muscle; decrease endogenous glucose production |
| Thiazolidinedions | pioglitazone (Actos); rosiglitazone (Avandia) |
| Action of Amlin Analog (SubQ) | Decrease gastric emptying; decrease glucagon secretion; decrease endogenous glucose output from liver; increase satiety |
| Amlin Analog (SubQ | pramlintide (Symlin) |
| Avandamet | Combination Therapy (rosiglitazone and metformin) |
| Glugovance | Combination Therapy (metformin and glyburide) |
| Metaglip | Combination Therapy (metformin and glipiaide) |
| Duetact | Combination Therapy (pioglitazone and plimepiride) |